Reckitt Benckiser has issued a voluntary recall for Mead Johnson Nutrition brand's baby formula powder. The U.S. Food and Drug Administration (US FDA) said that the health and nutrition firm decided to recall some batches of the said product due to possible bacterial contamination.
As per CNBC, the affected infant formula is being sold in the market as Nutramigen Powder. This infant formula is specially made for babies allergic to cow's milk. The recalled batches were produced in June and distributed to stores in the summer.
Recalled Batches of Nutramigen Powder
Reckitt Benckiser said that so far, it has not received any reports of illnesses or adverse effects related to the recalled Nutramigen Powder. However, the company is urging customers who have bought the milk formula to check the can to see if what they purchased is included in the batches that may have been contaminated.
The company said that the affected products have these batch numbers and their corresponding can sizes: ZL3FHG, 12.6 oz cans, ZL3FMH, 12.6 oz cans, ZL3FPE, 12.6 oz cans, ZL3FQD, 12.6 oz cans, ZL3FRW, 19.8 oz cans, and ZL3FXJ, 12.6 oz cans.
Adverse Effects of Bacterial Infection
Fox Business says the total number of the affected Nutramigen infant powder is about 675,030 cans. The FDA warned on Sunday, Dec. 31, that they may be contaminated with Cronobacter sakazakii.
The National Food Administration further said that the milk formula was made at a production facility in Michigan. The bacteria in the product potentially cause severe infections such as meningitis and sepsis. The FDA listed jaundice, irritability, temperature change, poor feeding, trouble breathing, and unusual movements as the common symptoms of the infection.
Meanwhile, the announcement stressed, "No other U.S. distributed Nutramigen batches or other Reckitt products are impacted."
Photo by: Reckltt Press Release


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



